News For GSK From The Last 14 Days Check below for free stories on GSK the last two weeks.
There are 13 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 2, 2012
|
| 06:00 EDT |  | GSK |
| theflyonthewall.com: | Ligand Pharmaceuticals' Melphalan shows succesful results in Phase II trial | | Ligand Pharmaceuticals (LGND) provided results from the Phase II study of its Captisol-enabled, propylene glycol-free Melphalan program. The Phase II study was completed in late 2011 and compared the safety, tolerability and pharmacokinetic profiles of the PG-free Melphalan intravenous formulation and the current clinically-used intravenous formulation of melphalan, sold by GlaxoSmithKline (GSK) as Alkeran for Injection, for multiple myeloma patients undergoing autologous transplantation. The Captisol-enabled product is expected to allow for longer administration durations and slower infusion rates, potentially enabling a higher dose intensity of pre-transplant chemotherapy. The new PG-free Melphalan was bioequivalent to Alkeran per guidance requirements, while also demonstrating a marginally higher systemic drug exposure of the multiple myeloma patients. Based on the successful Phase II results, the follow-on Pivotal study will utilize a dosing regimen comparable to Alkeran. :theflyonthewall.com |
|
|
February 1, 2012
|
| 15:06 EDT |  | GSK |
| | 14:16 EDT | | GSK |
| | 05:11 EDT | | GSK |
| theflyonthewall.com: | Prestige Brands Holdings completes purchase of 15 brands from GlaxoSmithKline |
 Subscribe for More Information :theflyonthewall.com |
|
|
January 31, 2012
|
| 08:16 EDT | | GSK |
| theflyonthewall.com: | Glaxo, Lilly, Pfizer, others interested in MN Pharms stake, Businessweek says |
Subscribe for More Information :theflyonthewall.com |
|
|
January 30, 2012
|
| 16:00 EDT |  | GSK |
| theflyonthewall.com: | The FDA Pediatric Advisory Committee to hold a meeting | | The Committee discusses pediatric-focused safety reviews, as mandated by Best Pharmaceuticals for Children Act and Pediatric Research Equity Act, for Wyeth Pharma's Prevnar 13 Vaccine and GlaxosmithKline's Cervarix Vaccine in a meeting to be held in Gaithersburg, Maryland on January 31 at 9 am. Webcast Link :theflyonthewall.com |
| | 05:35 EDT | | GSK |
| theflyonthewall.com: | News Corp.'s James Murdoch leaving GlaxoSmithKline board, Bloomberg reports | | News Corp.'s (NWSA) deputy COO James Murdoch is cutting some of his ties to London a and will leave the board of GlaxoSmithKline (GSK) after less than three years, Bloomberg reports. Reference Link :theflyonthewall.com |
|
|
January 26, 2012
|
| 11:09 EDT | | GSK |
|
|
January 25, 2012
|
| 09:10 EDT | | GSK |
| | 07:41 EDT | | GSK |
| | 06:52 EDT | | GSK |
|
|
January 24, 2012
|
| 07:20 EDT | | GSK |
| theflyonthewall.com: | SEC, others allege Stiefel family bought cheap shares before GSK sale, WSJ says |
Subscribe for More Information :theflyonthewall.com |
|
|
January 23, 2012
|
| 10:55 EDT | | GSK |
|
|
|
